BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02229396-completion@plaintrial.com
DTSTAMP:20261028T174804Z
DTSTART;VALUE=DATE:20171228
SUMMARY:Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to 
 Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Ve
 rsus Exenatide and Dapagliflozin Matching Placebo — estimated completion
  date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02229396
URL:https://plaintrial.com/trial/NCT02229396
END:VEVENT
END:VCALENDAR